Real-world data show that Enhertu benefits those with HR+ breast cancer, whereas Trodelvy is effective as an initial treatment for HER2-null/HER2– disease.

Dr. Jacob Sands explained that he believes patients should be having more personalized, nuanced conversations with their ...

There are many reliable resources available to patients with kidney cancer, as well as their families and caregivers.

Dr. Zev Wainberg of UCLA recently spoke with CURE about trial results concerning the cancer vaccine ELI-002 2P.

Follicular lymphoma survivor Troy Anderson credited acupuncture and nutrition guidance with easing treatment side effects and ...

Among patients with advanced gastrointestinal stromal tumors, Gleevec and Mektovi was associated with benefits in progression and survival.

CURE TV® is a production of countless expert interviews and interactive videos to help guide patients with cancer through all stages of the cancer continuum.